Background and aims Cholestatic liver disease is characterized by gut dysbiosis and excessive toxic hepatic bile acids (BAs). Modification of gut microbiota and repression of BA synthesis are potential strategies for the treatment of cholestatic liver disease. The purpose of this study was to examin...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!